Andrographis paniculata extract: Clinical Trials

2 trials of Andrographis paniculata extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Andrographis paniculata extract: new trials by email Literature Review of Andrographis paniculata extract trials Research Report on Andrographis paniculata extract

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment
Andrographis and Withania, Placebo - Cognitive Impairment, Mild
Phase 1CompletedEuroPharma, Inc.162019-04-012019-11-14
Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)
1 - Andrographis paniculata p/st extract, 2 - Excipients - Multiple Sclerosis, Relapsing-Remitting
Phase 1 / Phase 2CompletedUniversidad Austral de Chile302012-01-012016-06-23

Conditions studied

Cognitive Dysfunction (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Nervous System Diseases (1)

Sponsors

EuroPharma, Inc. (1)  ·  Universidad Austral de Chile (1)

Countries

Chile (1)  ·  Germany (1)

Top investigators

Juan L. Hancke, PhD (1)  ·  Klaus Koch, MD (1)

Results publications

PMID 27215274